Etherea Gino I
Natural health product licensed in Canada
- Other names
- HB GinoI, Health Balance Gino I, Health Element Gino I
- Licence holder
- Etherea Natural Foods Inc.
- NPN or DIN-HM
- 80080453
- Status
- Active licence
- Licence date
- 5 October 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Panax ginseng Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,500 mg Potency : 20 % Total ginsenosides | 150 mg | Not calculated |
| Panax quinquefolius Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,500 mg Potency : 10 % Ginsenosides | 300 mg | Not calculated |
| Panax notoginseng Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 250 mg | 50 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose microcristalline, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
(Used in Herbal Medicine as) supportive therapy for the promotion of healthy glucose levels. Panax quinquefolius is traditionally used in Herbal Medicine to help relieve nervous dyspepsia/to help digestion in cases of nervousness and/or stress.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use. If you experience symptoms of hypoglycaemia including feelings of anxiety, dizziness, tremor, sweating, nausea or headache, discontinue use and consult a health care practitioner.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking antidepressant medications. Consult a health care practitioner prior to use if you are taking blood thinners or digoxin. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner and discontinue use if symptoms persist or worsen, or if new symptoms develop. Consult a health care practitioner prior to use if you are taking prescription medications.
Source
Official Health Canada record, licence 80080453
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.